[Skip to Content]
[Skip to Content Landing]
July 1992

Topical Corticosteroids

Author Affiliations

Fort Lauderdale, Fla

Arch Dermatol. 1992;128(7):1001. doi:10.1001/archderm.1992.01680170137033

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


A text devoted to one form of therapy must overcome certain inherent obstacles. In order to appeal to researchers, technical aspects must be so exhaustive that they might overwhelm practitioners. This is particularly true if the science is not readily applicable or relevant to patient care. The physician expects to learn specific, useful regimens or techniques, a particular problem for topical corticosteroids, considering their familiarity.

The first section of Topical Corticosteroids discusses the pharmacology of these drugs. Stoughton's chapters on the vasoconstriction assay stand out as well written, pellucid, and direct. Otherwise, I—a clinician—found this section tedious and, even worse, expect it would be too elementary for those involved in pharmaceutical research.

The second section is devoted to clinical applications. The absence of novel or stimulating suggestions, I suspect, arises from the aforementioned familiarity we have with corticosteroids as well as the authors' reluctance to express a preference for one product over another. Any of the available

First Page Preview View Large
First page PDF preview
First page PDF preview